DeepChain.bio

DeepChain is an enterprise-grade, cloud-native AI platform developed by InstaDeep (part of the BioNTech AI ecosystem) to accelerate research and development across genomics, proteomics, and therapeutics. Built on extensive artificial intelligence research, the platform acts as an end-to-end system of action that eliminates traditional laboratory discovery bottlenecks by converting massive, multiomics datasets into clear, actionable biological insights. DeepChain equips biotechnology companies, life sciences labs, and pharmaceutical researchers with the advanced tools needed to analyze, design, and optimize complex biological sequences with minimal setup and high workflow flexibility.

DeepChain provides seamless, high-throughput cloud access to a suite of industry-leading foundational models optimized for distinct biological design challenges. Notable models include ProtBFN, which utilizes Bayesian Flow Networks to generate novel, biologically plausible protein sequences based on specific structural and functional properties, and AbBFN2, a multi-objective generative framework engineered specifically for automated antibody design and humanization. These are supported by InstaNovo and InstaNovo+, which leverage transformers and diffusion sampling to execute precise de novo peptide sequencing directly from raw mass spectrometry data without relying on reference databases.

Beyond structural and protein engineering, DeepChain delivers powerful genomic processing via its Nucleotide Transformers (NT) suite, including state-of-the-art updates like NTv3 and SegmentNT for single-nucleotide resolution mapping across whole genomes. It also features ChatNT, which enables researchers to interact with and query complex biological sequences using natural language. For agricultural biotechnology, DeepChain features AgroNT, a domain-adapted natural language processing model that analyzes plant genomes across dozens of species to predict functional traits, dramatically compressing years of standard molecular breeding and fieldwork into rapid, data-driven AI simulations.

Yes, DeepChain features a highly open, developer-first architecture supported by a flexible workflow framework and command-line interface (CLI). Through this collaborative hub, bioinformatics developers can build, run, and securely deploy custom scoring applications (such as custom classifiers or property predictors) that leverage DeepChain's internal GPU compute pools. These personalized solutions can then be directly linked within the platform's visual Folding Studio—which handles high-throughput screening of up to 10,000 designs per day—allowing research teams to evaluate mutations, optimize binding affinities, and minimize off-target risks simultaneously.